p21Waf1/Cip1 revisited: oncogenic function in hepatocellular carcinoma.
Goldyne Savad Institute of Gene Therapy, Hadassah University Hospital, Jerusalem, Israel.
Daniel
D
Goldenberg
Department for Internal Medicine I, Medical University Vienna & Comprehensive Cancer Center (CCC), Vienna, Austria.
Robert
R
Eferl
D000818:Animals; D063646:Carcinogenesis / Q000378:metabolism*; D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D002780:Cholestasis, Intrahepatic / Q000150:complications*; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000378:metabolism*; D005260:Female; D048550:Hepatic Insufficiency / Q000503:physiopathology*; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology*; D008115:Liver Regeneration / Q000502:physiology*; D008297:Male
D050759:Cyclin-Dependent Kinase Inhibitor p21
CELL CYCLE CONTROL; CHOLESTATIC LIVER DISEASES; HEPATOCELLULAR CARCINOMA